Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana.

@article{Bussmann2007PregnancyRA,
  title={Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana.},
  author={Hermann Bussmann and C William Wester and Carolyn N Wester and Bright Lekoko and Okechukwu A Okezie and Ann Muir Thomas and S M Victor DeGruttola and Joseph Makhema and Max Essex and Richard G. Marlink},
  journal={Journal of acquired immune deficiency syndromes},
  year={2007},
  volume={45 3},
  pages={
          269-73
        }
}
BACKGROUND Millions of HIV-infected women in developing countries are in need of safe and highly effective antiretroviral therapy. Pregnancy rates are usually high in developing countries, and efavirenz (EFV) use in women of childbearing age is of concern because of its potential teratogenicity. METHODS As part of a prospective study comparing 6 initial highly active antiretroviral therapy (HAART) regimens, 3 of which contained EFV, pregnancy and birth outcomes were evaluated among female… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS